Long-form reference material on hantavirus transmission biology, mortality, pandemic potential, and active outbreak surveillance. Editorial-grade content cross-referenced with primary sources.
Virion structure, the major strains (Andes, Sin Nombre, Hantaan, Puumala), HPS and HFRS clinical syndromes, geographic distribution, and the history of discovery — in one document.
Aerosolized rodent excreta is the primary route. Person-to-person spread is a documented exception for Andes virus only. Complete pathway analysis with prevention guidance.
For nearly every species, no. The Andes virus exception, the conditions required for person-to-person spread, the historical cluster record, and what R₀ < 1 means for risk.
CFRs by strain: Andes ~38%, Sin Nombre ~36%, Hantaan 5–15%, Puumala <1%. With historical context, mortality trends, and why high CFR doesn't equal pandemic risk.
A complete timeline of the Andes virus outbreak that spread across 14 countries via a single polar expedition cruise.
Climate-driven rodent population shifts, deforestation, and seasonal anomalies behind the highest case count since 2018.
Why the Andes virus, despite limited human-to-human transmission, is not on a pandemic trajectory comparable to COVID-19.
Why R₀, transmission mode, and viral mutation rate make hantavirus fundamentally different from a pandemic-capable pathogen.
The biphasic clinical course of HPS — why early symptoms mimic flu and when the disease becomes life-threatening.
How hantavirus moves from rodent excreta into human lungs — and why this is fundamentally different from human-to-human aerosol spread.